Research

What is a Clinical Research Trial?

Regulatory agencies like Health Canada and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials.

There are strict regulations that the trial doctors and their staff must follow when conducting Clinical Research Trials.

There are important things to know about participating in a Clinical Research Trial:

  1. Your participation is voluntary and you may withdraw at any time.
  2. All information about you will be kept confidential.
  3. Before you participate in a study a doctor or member of the Clinical Research team will explain all the details about the study to you, including any potential risks or benefits and answer all your questions.
  4. You will have as much time as you need to decide if you want to participate.
  5. If you decide to participate you will be asked to sign a consent form. You will get to keep a copy of this consent form which contains additional information about the Clinical Research Trial.

Every Clinical Research Trial is submitted to an Independent Research Ethics Board for approval before the study can be performed.

Active Clinical Trials

Psoriasis

Long Term Study of Daily Oral Tablets for Psoriasis
This study will look at the safety and effectiveness of long-term use of an investigational medication for psoriasis. Study participants must be generally healthy and at least 19 years of age with chronic, moderate to severe plaque-type psoriasis. Study participants will take the study medication tablets by mouth twice a day. The total time commitment for this study is up to 5 years and will involve up to 34 visits to the study clinic. There is no cost to participate and compensation for the time and travel associated with the study is provided.

9-Week Extensive Psoriasis Research Study Testing an Investigational Gel Medication
This research study is evaluating the safety and efficacy of an investigational gel medication, in subjects with extensive psoriasis vulgaris on the trunk and/or limbs. Study participants must be 19 years of age or older with a clinical diagnosis of psoriasis vulgaris involving non-scalp regions of the body (trunk and/or limbs) with or without involvement of the scalp. The time commitment for this study is approximately 9 weeks and involves about 7 visits to the study centre. There is no cost to participate. Study gel will need to be applied once daily, every day during the study.

Oral Therapy for Moderate to Severe Plaque Psoriasis
This research study is looking at the safety and effectiveness of an investigational medication for moderate to severe plaque psoriasis. Study participants must be 19 years of age or older and have been diagnosed with plaque-type psoriasis for at least 12 months. The time commitment for this study is approximately 1 year and involves 15 visits to the study centre. There is no cost to participate and study medication will be provided.

Psoriatic Arthritis

Oral Therapy for Psoriatic Arthritis Patients with at Least One Psoriatic Lesion
Psoriatic arthritis is a persistent condition characterized by inflammation of the skin (psoriasis) and joints (arthritis). This study is looking at the effectiveness of an investigational medication for psoriatic arthritis. Study participants must be 19 years of age or older, have been diagnosed with psoriatic arthritis for at least six months, and have at least one psoriatic lesion. The time commitment for this study is approximately 5 years. Initially, you will be asked to visit the study centre monthly; and then every 3 months for the remainder of the study. There is no cost to participate and study medication will be provided.

For more information regarding the above studies
please contact Alphaderm.

www.researchtrials.org

www.probitymedical.com